相关实验视频

Updated: Jul 19, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

用CD6向抗体与药物结合剂作为T细胞淋巴瘤的新治疗剂

Neetha Parameswaran¹, Liping Luo², Lingjun Zhang²

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

|August 12, 2023

概括

研究人员确定CD6是T细胞淋巴瘤 (TCL) 的有希望的治疗点. 一种新的CD6-向抗体-药物合物 (CD6-ADC) 在临床前模型中有效消除了TCL细胞并减少了瘤,为新的治疗提供了希望.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

细胞淋巴瘤 (TCL) 是一种具有有限向治疗选择的侵袭性癌症.
CD6是TCL患者样本上高度表达的T细胞标记物,表明其作为治疗点的潜力.

研究的目的:

研究CD6作为T细胞淋巴瘤的新型治疗点.
在TCL的临床前模型中评估CD6向抗体-药物合物的 (CD6-ADC) 疗效.

主要方法:

通过将MMAE毒素与抗CD6单克隆抗体结合,开发一个CD6-ADC.
在体外评估CD6-ADC对TCL细胞的细胞毒性.
在临床前TCL小鼠模型中对CD6-ADC的抗瘤活性进行体内评估.

主要成果:

在实验室中,CD6-ADC证明了TCL细胞的强效和选择性杀死.
在临床前的TCL模型中,CD6-ADC抑制了瘤的发展.
在体内,CD6-ADC的使用显著减少了已建立的瘤.

结论:

CD6是T细胞淋巴瘤的可行和新的治疗点.
CD6-ADC显示出显著的希望,作为一种潜在的新疗法,用于TCL患者.
进一步开发CD6-ADC有必要用于治疗这些侵袭性淋巴瘤瘤.

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.